Session Title:

David Krause, MD, FACP

Co-CEO & Chief Medical Officer, Genomind

About Me

Dr. David Krause is Co-Chief Executive Officer and Chief Medical Officer at Genomind. Board certified in internal medicine, Dr. Krause has more than 25 years of experience in pharmaceutical research and development and medical affairs. At Genomind, he is responsible for clinical research and serves as liaison to the community of Genomind’s patients, customers and subject matter experts. Prior to joining Genomind, Dr. Krause was the head of several global therapeutic areas at SmithKline Beecham and GlaxoSmithKline. He was also Chief Medical Officer at Vicuron Pharmaceuticals, which was acquired by Pfizer, Inc. in 2006.

Dr. Krause is a Fellow of the American College of Physicians, and author of more than 40 scientific publications and abstracts, and has served as a consultant to the Department of Defense.

Dr. Krause is a graduate of the Pennsylvania State University, where he was named a Centennial Fellow by the College of Liberal Arts, and received his MD degree from Temple University.


in-person & online

Earn up to 14 continuing education (CE) hours

In partnership with PESI, our event will offer CE credits for mental health professionals who attend. For those unable to make the trip to Arizona, the CE credits can be attained virtually via PESI's streaming platform during the live event.

Some of Our Speakers

To see more of our amazing speakers, click the button below.
View Profile
Lauren A. Lee, PhD

VP, Clinical Product and Content Development, Headspace Health

View Profile
Andrew Parker

Founder & CEO, Papa

View Profile
Dani Bicknell

Senior Program Manager, Headstream, SecondMuse

View Profile
Rick Doblin, PhD

Executive Director, Multidisciplinary Association for Psychedelic Studies (MAPS)